Advertisement

Asthma COPD Overlap (ACO)

  • Yasuhiro GonEmail author
  • Mari Hikichi
  • Shu Hashimoto
Chapter
Part of the Respiratory Disease Series: Diagnostic Tools and Disease Managements book series (RDSDTDM)

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are the most common chronic airway disorders worldwide. The overlap of asthma and COPD is a problem that has been discussed for a long time, and there was previously no unified name or definition of this condition. The Global Initiative for Asthma (GINA), an international committee examining asthma, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD), an international committee examining COPD, jointly proposed the concept of “Asthma/COPD Overlap Syndrome (ACOS)” (currently named “asthma/COPD overlap (ACO).” However, it is unclear how to identify ACO as a clinically useful disease entity. In this chapter, we discussed clinical features and biomarkers to differentiate asthma, COPD, and ACO in elderly patients on the basis of the definition of GINA guideline and described historical background and prevalence and treatment of ACO.

Keywords

Asthma Global Initiative for Chronic Obstructive Lung Disease (GOLD) Asthma/COPD overlap (ACO) Dutch hypothesis British hypothesis 

References

  1. 1.
    ER MF Jr. A century of asthma. Am J Respir Crit Care Med. 2004;170(3):215–21.CrossRefGoogle Scholar
  2. 2.
    Scott JA, Mahler DA. Diagnosis of chronic obstructive pulmonary disease and differentiation from asthma. Curr Opin Pulm Med. 1995;1(2):144–9.PubMedGoogle Scholar
  3. 3.
    Martinez FJ. Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema, and chronic bronchitis. Postgrad Med. 1998;103(4):112–7. 121–2, 125.CrossRefGoogle Scholar
  4. 4.
    Orie NGM, Sluiter HJ, de Vries K, Tammeling GJ, Witkop J. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, editors. Bronchitis. Assen: Royal van. Gorcum; 1961. p. 43–59.Google Scholar
  5. 5.
    Reid L. The role of chronic bronchitis in the production of “chronic obstructive pulmonary emphysema”. J Am Med Womens Assoc. 1965;20:633–8.PubMedGoogle Scholar
  6. 6.
    Soler X, Ramsdell JW. Are asthma and COPD a continuum of the same disease? J Allergy Clin Immunol Pract. 2015;3(4):489–95.CrossRefGoogle Scholar
  7. 7.
    Global initiative for asthma. Global strategy for asthma management and prevention. 2017. http://ginasthma.org/2017-gina-report-global-strategy-for-asthma-management-and-prevention/.
  8. 8.
    Global strategy for the diagnosis, Management and prevention of chronic obstructive pulmonary disease (GOLD). 2017.Google Scholar
  9. 9.
    Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59–65.CrossRefGoogle Scholar
  10. 10.
    Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, Wechsler ME. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–73.CrossRefGoogle Scholar
  11. 11.
    Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF, FLAME Investigators. Indacaterol-Glycopyrronium versus Salmeterol-fluticasone for COPD. N Engl J Med. 2016;374(23):2222–34.CrossRefGoogle Scholar
  12. 12.
    Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015;70(7):683–91.CrossRefGoogle Scholar
  13. 13.
    Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124:474–81.CrossRefGoogle Scholar
  14. 14.
    de Marco R, Marcon A, Rossi A, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015;46:671–9.CrossRefGoogle Scholar
  15. 15.
    Diaz-Guzman E, Khosravi M, Mannino DM. Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population. COPD. 2011;8:400–7.CrossRefGoogle Scholar
  16. 16.
    Menezes AM, Montes de Oca M, Pérez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145:297–304.CrossRefGoogle Scholar
  17. 17.
    de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8:e62985.CrossRefGoogle Scholar
  18. 18.
    Shirtcliffe P, Marsh S, Travers J, et al. Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J. 2012;42(1):83–8.CrossRefGoogle Scholar
  19. 19.
    Wurst KE, Kelly-Reif K, Bushnell GA, et al. Understanding asthma-chronic obstructive pulmonary disease overlap syndrome. Respir Med. 2016;110:1–11.CrossRefGoogle Scholar
  20. 20.
    Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–76.CrossRefGoogle Scholar
  21. 21.
    Alshabanat A, Zafari Z, Albanyan O, et al. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10:e0136065.CrossRefGoogle Scholar
  22. 22.
    Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3:435–42.CrossRefGoogle Scholar
  23. 23.
    Cosio BG, Soriano JB, López-Campos JL, et al. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016;149:45–52.CrossRefGoogle Scholar
  24. 24.
    Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44:341–50.CrossRefGoogle Scholar
  25. 25.
    Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107:1053–60.CrossRefGoogle Scholar
  26. 26.
    Ichinose M, Sugiura H, Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000;162:701–6.CrossRefGoogle Scholar
  27. 27.
    Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–15.CrossRefGoogle Scholar
  28. 28.
    Rutgers SR, Timens W, Kaufmann HF, et al. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J. 2000;15:109–15.CrossRefGoogle Scholar
  29. 29.
    Eltboli O, Bafadhel M, Hollins F, et al. COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils. BMC Pulm Med. 2014;14:112.CrossRefGoogle Scholar
  30. 30.
    Pizzichini E, Pizzichini MM, Gibson P, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158:1511–7.CrossRefGoogle Scholar
  31. 31.
    Brightling CE, Monteiro W, Ward R, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease:a randomised controlled trial. Lancet. 2000;356:1480–5.CrossRefGoogle Scholar
  32. 32.
    Brightling CE, McKenna S, Hargadon B, et al. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax. 2005;60:193–8.CrossRefGoogle Scholar
  33. 33.
    Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease:identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662–71.CrossRefGoogle Scholar
  34. 34.
    Kolsum U, Damera G, Pham TH, Southworth T, Mason S, Karur P, Newbold P, Singh D. Pulmonary inflammation in patients with chronic obstructive pulmonary disease with higher blood eosinophil counts. J Allergy Clin Immunol. 2017;140(4):1181–1184.e7.CrossRefGoogle Scholar
  35. 35.
    Eltboli O, Mistry V, Barker B, et al. Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease. Respirology. 2015;20:667–70.CrossRefGoogle Scholar
  36. 36.
    Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. The copenhagen general population study. Am J Respir Crit Care Med. 2016;193:965–74.CrossRefGoogle Scholar
  37. 37.
    Singh D, Kolsum U, Brightling CE, et al. Eosinophilic inflammation in COPD:prevalence and clinical characteristics. Eur Respir J. 2014;44:1697–700.CrossRefGoogle Scholar
  38. 38.
    Iwamoto H, Gao J, Koskela J, Kinnula V, Kobayashi H, Laitinen T, Mazur W. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap. Eur Respir J. 2014;43(2):421–9.CrossRefGoogle Scholar
  39. 39.
    Gao J, Iwamoto H, Koskela J, Alenius H, Hattori N, Kohno N, Laitinen T, Mazur W, Pulkkinen V. Characterization of sputum biomarkers for asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2016;30(11):2457–65.CrossRefGoogle Scholar
  40. 40.
    James AJ, Reinius LE, Verhoek M, Gomes A, Kupczyk M, Hammar U, Ono J, Ohta S, Izuhara K, Bel E, Kere J, Söderhäll C, Dahlén B, Boot RG, Dahlén SE, BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium. Increased YKL-40 and Chitotriosidase in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;193(2):131–42.CrossRefGoogle Scholar
  41. 41.
    Gon Y, Maruoka S, Ito R, Mizumura K, Kozu Y, Hiranuma H, Hattori T, Takahashi M, Hikichi M, Hashimoto S. Utility of serum YKL-40 levels for identification of patients with asthma and COPD. Allergol Int. 2017;66(4):624–6.CrossRefGoogle Scholar
  42. 42.
    Ichinose M. Asthma prevention and management guideline 2015. Arerugi. 2017;66(2):77–81.PubMedGoogle Scholar
  43. 43.
    Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904–12.CrossRefGoogle Scholar
  44. 44.
    Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3(9):719–28.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Division of Respiratory Medicine, Department of Internal MedicineNihon University School of MedicineItabashi-kuJapan

Personalised recommendations